Parmax Pharma Ltd () News & Corporate Actions | Announcements, Board Meetings, Splits, Bonuses, Rights Issues

{ "main_header": { "sid": 1002724, "name": "Parmax Pharma", "stock_name": "Parmax Pharma", "full_name": "Parmax Pharma Ltd", "name_url": "stocks-analysis/parmax-pharma", "exchange": 0, "exchangecode": "", "primexch": 0, "country_id": 34, "currency": "INR", "cmp": "68.02", "chg": 1.33, "chgp": "1.99%", "dir": 1, "prev_price": "66.69", "mcapval": "25.00 Cr", "mcap": "Micro Cap", "scripcode": 540359, "symbol": "", "ind_name": "Pharmaceuticals & Biotechnology", "ind_code": 4, "sector_id": 65, "indexname": "India SENSEX", "isin": "INE240T01014", "curr_date": "Jun 18, 10:16 AM", "curr_time": "10:29 AM", "last_traded_at": "Jun 18, 10:16 AM IST", "bse_nse_vol": "200 ", "exc_status": "Active", "traded_date": "Jun 18, 2026", "traded_date_str": "2026 06 18", "score": "", "scoreText": "", "Live": 1, "market_time": 1, "is_blur": 1, "is_blur_class": "blur-register-score-header", "is_blur_url": "https://www.marketsmojo.com/mojofeed/register?redirect=/stocks-analysis/parmax-pharma-1002724-0&utm_source=Spage_Header_Score", "mojoone": { "ismore": 0 } }, "news": { "results": [ { "title": "Broad-Based Technical Strength Lifts Parmax Pharma Ltd to 52-Week High of Rs 66.69", "link": "https://www.marketsmojo.com/news/stocks-in-action/parmax-pharma-ltd-hits-new-52-week-high-at-rs6669-4058981", "imagepath": "https://i.marketsmojo.com/newsimg/2026/6/ParmaxPharmaLtd_priceRelatedfactors_4058981.png", "date": "2026-06-17 10:47:15", "description": "Surging to a new 52-week high of Rs 66.69 on 17 Jun 2026, Parmax Pharma Ltd has demonstrated remarkable price momentum, rallying 45.83% over the past eight consecutive trading days. This surge has propelled the stock well above all key moving averages, signalling robust technical strength amid a broadly positive market backdrop." }, { "title": "Broad-Based Technical Strength Lifts Parmax Pharma Ltd to 52-Week High of Rs 65.39", "link": "https://www.marketsmojo.com/news/stocks-in-action/parmax-pharma-ltd-hits-new-52-week-high-at-rs6539-4055624", "imagepath": "https://i.marketsmojo.com/newsimg/2026/6/ParmaxPharmaLtd_priceRelatedfactors_4055624.png", "date": "2026-06-16 09:51:12", "description": "With a decisive surge to Rs 65.39 on 16 Jun 2026, Parmax Pharma Ltd has reached a fresh 52-week high, marking a remarkable 189% increase from its low of Rs 22.60 over the past year. This rally is underpinned by a confluence of bullish technical indicators and sustained price momentum, setting the stage for a noteworthy milestone in the micro-cap pharmaceutical space." }, { "title": "Broad-Based Technical Strength Lifts Parmax Pharma Ltd to 52-Week High of Rs 62.28", "link": "https://www.marketsmojo.com/news/stocks-in-action/parmax-pharma-ltd-hits-new-52-week-high-at-rs6228-4054008", "imagepath": "https://i.marketsmojo.com/newsimg/2026/6/ParmaxPharmaLtd_priceRelatedfactors_4054008.png", "date": "2026-06-15 09:58:14", "description": "Surging past its previous peaks, Parmax Pharma Ltd touched a fresh 52-week high of Rs 62.28 on 15 Jun 2026, marking a remarkable rally of 60.93% over the past year against a declining Sensex. This milestone caps a six-day winning streak that has propelled the stock 36.19% higher, fuelled by a confluence of bullish technical indicators and sustained price momentum." }, { "title": "Parmax Pharma Surges 23.49% Amid 52-Week High and Earnings Woes", "link": "https://www.marketsmojo.com/news/stocks-in-action/parmax-pharma-surges-2349-amid-52-week-high-and-earnings-woes-4052000", "imagepath": "", "date": "2026-06-13 16:14:52", "description": " <div class=\"article-news-new\">\n <div class=\"article-container\">\n\n<div class=\"article-content\">\n <div class=\"highlight-box\">\n <h3>Key Events This Week</h3>\n <p><strong>1 June:</strong> Stock opens strong at Rs.39.00 (+5.32%) amid broad market weakness</p>\n <p><strong>2 June:</strong> Continued gains with Rs.40.67 close (+4.28%) as volume picks up</p>\n <p><strong>3 June:</strong> Sharp rally to Rs.44.49 (+9.39%) despite Sensex dip</p>\n <p><strong>4 June:</strong> New 52-week high of Rs.53.38 reached; Q4 FY26 results reveal mounting losses</p>\n <p><strong>5 June:</strong> Profit-taking leads to Rs.45.73 close (-10.44%) on lower volume</p>\n </div>\n\n <div class=\"stats-row\">\n <div class=\"stat-item\"><div class=\"stat-label\">Week ..." }, { "title": "Broad-Based Technical Strength Lifts Parmax Pharma Ltd to 52-Week High of Rs 59.32", "link": "https://www.marketsmojo.com/news/stocks-in-action/parmax-pharma-ltd-hits-new-52-week-high-at-rs5932-4048631", "imagepath": "https://i.marketsmojo.com/newsimg/2026/6/ParmaxPharmaLtd_priceRelatedfactors_4048631.png", "date": "2026-06-12 09:47:39", "description": "With a decisive surge to Rs 59.32 on 12 Jun 2026, Parmax Pharma Ltd has reached a new 52-week high, marking a remarkable 162% increase from its low of Rs 22.6 over the past year. This rally is underpinned by a strong alignment of technical indicators and sustained price momentum, setting the stock apart in a market where the Sensex remains below its 50-day moving average." }, { "title": "Broad-Based Technical Strength Lifts Parmax Pharma Ltd to 52-Week High of Rs 56.5", "link": "https://www.marketsmojo.com/news/stocks-in-action/parmax-pharma-ltd-hits-new-52-week-high-at-rs565-4046211", "imagepath": "https://i.marketsmojo.com/newsimg/2026/6/ParmaxPharmaLtd_priceRelatedfactors_4046211.png", "date": "2026-06-11 09:43:04", "description": "Surging to a fresh 52-week high of Rs 56.5 on 11 Jun 2026, Parmax Pharma Ltd has demonstrated remarkable price momentum, outperforming its sector and the broader market despite a bearish backdrop for the Sensex." }, { "title": "Broad-Based Technical Strength Lifts Parmax Pharma Ltd to 52-Week High of Rs 53.81", "link": "https://www.marketsmojo.com/news/stocks-in-action/parmax-pharma-ltd-hits-new-52-week-high-at-rs5381-4043708", "imagepath": "https://i.marketsmojo.com/newsimg/2026/6/ParmaxPharmaLtd_priceRelatedfactors_4043708.png", "date": "2026-06-10 09:45:13", "description": "With a decisive 5% gap-up opening and a sustained rally to Rs 53.81, Parmax Pharma Ltd has surged to a fresh 52-week high, marking a 41.64% gain over the past year against a declining Sensex. This technical breakout underscores a strong momentum phase for the micro-cap pharmaceutical player." }, { "title": "Parmax Pharma Q4 FY26: Mounting Losses Signal Deepening Crisis", "link": "https://www.marketsmojo.com/news/result-analysis/parmax-pharma-q4-fy26-mounting-losses-signal-deepening-crisis-4036066", "imagepath": "https://i.marketsmojo.com/newsimg/2026/6/ParmaxPharma_quaterlyResult_4036066.png", "date": "2026-06-04 09:53:10", "description": "Parmax Pharma Ltd., a micro-cap pharmaceutical company specialising in Active Pharmaceutical Ingredients (API) and Contract Manufacturing Operations (CMO), reported a net loss of ₹0.58 crores for Q4 FY26 (Jan-Mar'26), marking the seventh consecutive quarter of losses. Whilst the loss narrowed sequentially from ₹0.73 crores in Q3 FY26, it remains significantly lower than the ₹1.49 crores loss in Q4 FY25. The company's shares surged 16.88% to ₹52.00 following the results, despite the troubling financial performance, suggesting speculative trading rather than fundamental improvement." }, { "title": "Broad-Based Technical Strength Lifts Parmax Pharma Ltd to 52-Week High of Rs 53.38", "link": "https://www.marketsmojo.com/news/stocks-in-action/parmax-pharma-ltd-hits-new-52-week-high-of-rs5338-on-4-june-2026-4035643", "imagepath": "https://i.marketsmojo.com/newsimg/2026/6/ParmaxPharmaLtd_priceRelatedfactors_4035643.png", "date": "2026-06-04 09:50:31", "description": "With a surge to Rs 53.38 on 4 Jun 2026, Parmax Pharma Ltd has reached a fresh 52-week high, propelled by a striking alignment of technical indicators and sustained price momentum that outpaces its sector and the broader market." } ], "total": 127, "sid": "1002724", "stock_news_url": "https://www.marketsmojo.com/news/parmax-pharma-1002724" }, "announcements": [ { "caption": "Detailed Public Statement", "datetime": "15-Jun-2026", "details": "Fedex Securities Pvt Ltd (Manager to the Offer) has submitted to BSE a copy of Detailed Public Statement in terms of Regulations 3(1) and 4 read with Regulations 13(4) 14 (3) and 15(2) and other applicable Regulations of the Securities and Exchange Board of India (Substantial Acquisition of Shares and Takeovers) Regulations 2011 as amended (SEBI (SAST) Regulations 2011) to the Publicshareholders of Parmax Pharma Limited (Target Company).", "source": "BSE" }, { "caption": "Announcement under Regulation 30 (LODR)-Newspaper Publication", "datetime": "11-Jun-2026", "details": "Regarding Notice of EGM and E-voting", "source": "BSE" }, { "caption": "Open Offer", "datetime": "09-Jun-2026", "details": "Fedex Securities Pvt Ltd (Manager to the Offer) has submitted to BSE a copy of Public Announcement under Regulation 3(1) And Regulation 4 Read with Regulation 13 Regulation 14 And Regulation 15(1) of the Securities and Exchange Board of India (Substantial Acquisition Of Shares And Takeovers) Regulations 2011 And Subsequent Amendments thereto for the Attention of the Public Shareholders of Parmax Pharma Limited (Target Company).", "source": "BSE" } ], "corporate_actions": [ { "img": "board-meeting.svg", "title": "BOARD MEETING", "msg": "<span>No</span> Upcoming Board Meetings", "data": [] }, { "img": "dividend.svg", "title": "DIVIDEND", "msg": "No <strong>Dividend</strong> history available", "data": [] }, { "img": "splits.svg", "title": "SPLITS", "msg": "No <strong>Splits</strong> history available", "data": [] }, { "img": "bonus.svg", "title": "BONUS", "msg": "No <strong>Bonus</strong> history available", "data": [] }, { "img": "rights-issues.svg", "title": "RIGHTS", "msg": "No <strong>Rights</strong> history available", "data": [] } ] }

Key Events This Week

1 June: Stock opens strong at Rs.39.00 (+5.32%) amid broad market weakness

2 June: Continued gains with Rs.40.67 close (+4.28%) as volume picks up

3 June: Sharp rally to Rs.44.49 (+9.39%) despite Sensex dip

4 June: New 52-week high of Rs.53.38 reached; Q4 FY26 results reveal mounting losses

5 June: Profit-taking leads to Rs.45.73 close (-10.44%) on lower volume

Week ...

Read full news article

Broad-Based Technical Strength Lifts Parmax Pharma Ltd to 52-Week High of Rs 59.32

2026-06-12 09:47:39

With a decisive surge to Rs 59.32 on 12 Jun 2026, Parmax Pharma Ltd has reached a new 52-week high, marking a remarkable 162% increase from its low of Rs 22.6 over the past year. This rally is underpinned by a strong alignment of technical indicators and sustained price momentum, setting the stock apart in a market where the Sensex remains below its 50-day moving average.

Read full news article

Broad-Based Technical Strength Lifts Parmax Pharma Ltd to 52-Week High of Rs 56.5

2026-06-11 09:43:04

Surging to a fresh 52-week high of Rs 56.5 on 11 Jun 2026, Parmax Pharma Ltd has demonstrated remarkable price momentum, outperforming its sector and the broader market despite a bearish backdrop for the Sensex.

Read full news article

Broad-Based Technical Strength Lifts Parmax Pharma Ltd to 52-Week High of Rs 53.81

2026-06-10 09:45:13

With a decisive 5% gap-up opening and a sustained rally to Rs 53.81, Parmax Pharma Ltd has surged to a fresh 52-week high, marking a 41.64% gain over the past year against a declining Sensex. This technical breakout underscores a strong momentum phase for the micro-cap pharmaceutical player.

Read full news article

Parmax Pharma Q4 FY26: Mounting Losses Signal Deepening Crisis

2026-06-04 09:53:10

Parmax Pharma Ltd., a micro-cap pharmaceutical company specialising in Active Pharmaceutical Ingredients (API) and Contract Manufacturing Operations (CMO), reported a net loss of ₹0.58 crores for Q4 FY26 (Jan-Mar'26), marking the seventh consecutive quarter of losses. Whilst the loss narrowed sequentially from ₹0.73 crores in Q3 FY26, it remains significantly lower than the ₹1.49 crores loss in Q4 FY25. The company's shares surged 16.88% to ₹52.00 following the results, despite the troubling financial performance, suggesting speculative trading rather than fundamental improvement.

Read full news article

Broad-Based Technical Strength Lifts Parmax Pharma Ltd to 52-Week High of Rs 53.38

2026-06-04 09:50:31

With a surge to Rs 53.38 on 4 Jun 2026, Parmax Pharma Ltd has reached a fresh 52-week high, propelled by a striking alignment of technical indicators and sustained price momentum that outpaces its sector and the broader market.

Read full news article